Immunoglobulins | Tenderlake

Immunoglobulins

Contract Value:
GBP 648M - 648M
Notice Type:
Contract Notice
Published Date:
23 March 2017
Closing Date:
28 April 2017
Location(s):
UKC NORTH EAST (ENGLAND) (UK UNITED KINGDOM)
UKD NORTH WEST (ENGLAND) (UK UNITED KINGDOM)
UKE YORKSHIRE AND THE HUMBER (UK UNITED KINGDOM)
UKF EAST MIDLANDS (ENGLAND) (UK UNITED KINGDOM)
UKG WEST MIDLANDS (ENGLAND) (UK UNITED KINGDOM)
UKH EAST OF ENGLAND (UK UNITED KINGDOM)
UKI LONDON (UK UNITED KINGDOM)
UKJ SOUTH EAST (ENGLAND) (UK UNITED KINGDOM)
UKK SOUTH WEST (ENGLAND) (UK UNITED KINGDOM)
UKN NORTHERN IRELAND (UK UNITED KINGDOM)
Description:

NHS National Framework Agreement for the Supply of Immunoglobulin. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1.6.2017 for a period of 1 year until 31.5.2018, with options to extend for up to a further 36 months. Please refer to the Invitation of Offer documents for the list of Pharmacy Purchasing Points.


Normal Human Immunoglobulin for Intravenous Use

NHS National Framework Agreement for the Supply of Immunoglobulin. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1.6.2017 for a period of 1 year until 31.5.2018, with options to extend for up to a further 36 months. Please refer to the Invitation of Offer documents for the list of Pharmacy Purchasing Points.


Normal Human Immunoglobulin for Subcutaneous Use

NHS National Framework Agreement for the Supply of Immunoglobulin. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1.6.2017 for a period of 1 year until 31.5.2018, with options to extend for up to a further 36 months. Please refer to the Invitation of Offer documents for the list of Pharmacy Purchasing Points.

Download full details as .pdf
The Buyer:
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
CPV Code(s):
33651520 - Immunoglobulins